Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV‐8‐negative multicentric Castleman disease. Issue 2 (February 2016)
- Record Type:
- Journal Article
- Title:
- Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV‐8‐negative multicentric Castleman disease. Issue 2 (February 2016)
- Main Title:
- Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV‐8‐negative multicentric Castleman disease
- Authors:
- Iwaki, Noriko
Fajgenbaum, David C.
Nabel, Christopher S.
Gion, Yuka
Kondo, Eisei
Kawano, Mitsuhiro
Masunari, Taro
Yoshida, Isao
Moro, Hiroshi
Nikkuni, Koji
Takai, Kazue
Matsue, Kosei
Kurosawa, Mitsutoshi
Hagihara, Masao
Saito, Akio
Okamoto, Masataka
Yokota, Kenji
Hiraiwa, Shinichiro
Nakamura, Naoya
Nakao, Shinji
Yoshino, Tadashi
Sato, Yasuharu - Abstract:
- Abstract : Multicentric Castleman disease (MCD) describes a heterogeneous group of disorders involving systemic inflammation, characteristic lymph node histopathology, and multi‐organ dysfunction because of pathologic hypercytokinemia. Whereas Human Herpes Virus‐8 (HHV‐8) drives the hypercytokinemia in a cohort of immunocompromised patients, the etiology of HHV‐8‐negative MCD is idiopathic (iMCD). Recently, a limited series of iMCD cases in Japan sharing a constellation of clinical features, including thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O) has been described as TAFRO syndrome. Herein, we report clinicopathological findings on 25 patients (14 males and 11 females; 23 Japanese‐born and two US‐born), the largest TAFRO syndrome case series, including the first report of cases from the USA. The median age of onset was 50 years old (range: 23–72). The frequency of each feature was as follows: thrombocytopenia (21/25), anasarca (24/25), fever (21/25), organomegaly (25/25), and reticulin fibrosis (13/16). These patients frequently demonstrated abdominal pain, elevated serum alkaline phosphatase levels, and acute kidney failure. Surprisingly, none of the cases demonstrated marked hypergammoglobulinemia, which is frequently reported in iMCD. Lymph node biopsies revealed atrophic germinal centers with enlarged nuclei of endothelial cells and proliferation of endothelial venules in interfollicular zone. 23 of 25 cases were treatedAbstract : Multicentric Castleman disease (MCD) describes a heterogeneous group of disorders involving systemic inflammation, characteristic lymph node histopathology, and multi‐organ dysfunction because of pathologic hypercytokinemia. Whereas Human Herpes Virus‐8 (HHV‐8) drives the hypercytokinemia in a cohort of immunocompromised patients, the etiology of HHV‐8‐negative MCD is idiopathic (iMCD). Recently, a limited series of iMCD cases in Japan sharing a constellation of clinical features, including thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O) has been described as TAFRO syndrome. Herein, we report clinicopathological findings on 25 patients (14 males and 11 females; 23 Japanese‐born and two US‐born), the largest TAFRO syndrome case series, including the first report of cases from the USA. The median age of onset was 50 years old (range: 23–72). The frequency of each feature was as follows: thrombocytopenia (21/25), anasarca (24/25), fever (21/25), organomegaly (25/25), and reticulin fibrosis (13/16). These patients frequently demonstrated abdominal pain, elevated serum alkaline phosphatase levels, and acute kidney failure. Surprisingly, none of the cases demonstrated marked hypergammoglobulinemia, which is frequently reported in iMCD. Lymph node biopsies revealed atrophic germinal centers with enlarged nuclei of endothelial cells and proliferation of endothelial venules in interfollicular zone. 23 of 25 cases were treated initially with corticosteroids; 12 patients responded poorly and required further therapy. Three patients died during the observation period (median: 9 months) because of disease progression or infections. TAFRO syndrome is a unique subtype of iMCD that demonstrates characteristic clinicopathological findings. Further study to clarify prognosis, pathophysiology, and appropriate treatment is needed. Am. J. Hematol. 91:220–226, 2016. © 2015 Wiley Periodicals, Inc. … (more)
- Is Part Of:
- American journal of hematology. Volume 91:Issue 2(2016:Feb.)
- Journal:
- American journal of hematology
- Issue:
- Volume 91:Issue 2(2016:Feb.)
- Issue Display:
- Volume 91, Issue 2 (2016)
- Year:
- 2016
- Volume:
- 91
- Issue:
- 2
- Issue Sort Value:
- 2016-0091-0002-0000
- Page Start:
- 220
- Page End:
- 226
- Publication Date:
- 2016-02
- Subjects:
- Hematology -- Periodicals
616.15 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-8652 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ajh.24242 ↗
- Languages:
- English
- ISSNs:
- 0361-8609
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0824.800000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 1693.xml